CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Interest Expense : $0.00 Mil (TTM As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CTT Pharmaceutical Holdings's interest expense for the three months ended in Jun. 2018 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2018 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CTT Pharmaceutical Holdings's Operating Income for the three months ended in Jun. 2018 was $ -1.09 Mil. CTT Pharmaceutical Holdings's Interest Expense for the three months ended in Jun. 2018 was $ 0.00 Mil. GuruFocus does not calculate CTT Pharmaceutical Holdings's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CTT Pharmaceutical Holdings Interest Expense Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings Interest Expense Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Interest Expense

Get a 7-Day Free Trial

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

CTT Pharmaceutical Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

CTT Pharmaceutical Holdings (OTCPK:CTTH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CTT Pharmaceutical Holdings's Interest Expense for the three months ended in Jun. 2018 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2018 was $-1.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2018 was $0.04 Mil.

CTT Pharmaceutical Holdings's Interest Coverage for the quarter that ended in Jun. 2018 is calculated as

GuruFocus does not calculate CTT Pharmaceutical Holdings's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives